Literature DB >> 11685602

Molecular pathophysiology of tubular transport disorders.

I Zelikovic1.   

Abstract

Inherited tubular transport disorders comprise a group of diseases that lead to profound derangements in the homeostasis of electrolytes, minerals, or organic solutes in the body. In the past decade remarkable progress has been made in our understanding of the molecular pathogenesis of hereditary tubulopathies and the fundamental molecular physiology of renal tubular transport processes. This review summarizes hereditary diseases caused by mutations in genes encoding transporter or channel proteins operating along the renal tubule. Review of the molecular basis of hereditary tubulopathies reveals various loss-of-function or gain-of-function mutations in genes encoding cotransporter, exchanger, or channel proteins, which are located in the luminal, basolateral, or endosomal membranes of the tubular cell or in paracellular tight junctions. These gene mutations result in a variety of functional defects in transporter/channel proteins, including decreased activity, impaired gating, defective trafficking, impaired endocytosis and degradation, or defective assembly of channel subunits. Further molecular studies of inherited tubular transport disorders may shed more light on the molecular pathophysiology of these diseases and may significantly improve our understanding of the mechanisms underlying renal salt homeostasis, urinary mineral excretion, and blood pressure regulation in health and disease. The identification of the molecular defects in inherited tubulopathies may provide a basis for future design of targeted therapeutic interventions and, possibly, strategies for gene therapy of these complex disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11685602     DOI: 10.1007/s004670100671

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  Renal physiology in newborns and old people: similar characteristics but different mechanisms.

Authors:  Carlos G Musso; Lidia Ghezzi; Jorge Ferraris
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

2.  Fanconi-Bickel syndrome as an example of marked allelic heterogeneity.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2012-06-06

3.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

4.  Hereditary renal tubular disorders in Turkey: demographic, clinical, and laboratory features.

Authors:  Rezan Topaloglu; Esra Baskın; Elif Bahat; Salih Kavukcu; Nilgun Cakar; Osman Donmez; Ayfer Gur Guven; Salim Calıskan; Ozlem Erdogan; Fatos Yalcınkaya
Journal:  Clin Exp Nephrol       Date:  2010-11-20       Impact factor: 2.801

Review 5.  Genetic diagnosis and treatment of hereditary renal tubular disease with hypokalemia and alkalosis.

Authors:  Wenkai Guo; Pengcheng Ji; Yuansheng Xie
Journal:  J Nephrol       Date:  2022-08-22       Impact factor: 4.393

6.  RenalTube: a network tool for clinical and genetic diagnosis of primary tubulopathies.

Authors:  Natalia Mejía; Fernando Santos; Félix Claverie-Martín; Víctor García-Nieto; Gema Ariceta; Luis Castaño
Journal:  Eur J Pediatr       Date:  2013-02-07       Impact factor: 3.183

Review 7.  Prevention of cardiac arrhythmias in pediatric patients with normotensive-hypokalemic tubulopathy. Current attitude among European pediatricians.

Authors:  Cinzia Cortesi; Pietro E G Foglia; Alberto Bettinelli; Mario G Bianchetti
Journal:  Pediatr Nephrol       Date:  2003-08       Impact factor: 3.714

8.  Molecular pathophysiology of renal tubular acidosis.

Authors:  P C B Pereira; D M Miranda; E A Oliveira; A C Simões E Silva
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

9.  Organization of the pronephric kidney revealed by large-scale gene expression mapping.

Authors:  Daniela Raciti; Luca Reggiani; Lars Geffers; Qiuhong Jiang; Francesca Bacchion; Astrid E Subrizi; Dave Clements; Christopher Tindal; Duncan R Davidson; Brigitte Kaissling; André W Brändli
Journal:  Genome Biol       Date:  2008-05-20       Impact factor: 13.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.